World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
58326
World Ranking
4870
National Ranking
266

Overview

Peter Neuhaus is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily focuses on medical sciences with an emphasis on hepatology, oncology, and related fields.

The scientist has contributed extensively to several subfields of study including:

  • Hepatology
  • Oncology
  • Epidemiology
  • Surgery
  • Pulmonary and Respiratory Medicine

Neuhaus's main areas of work cover key topics such as:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Colorectal Cancer Treatments and Studies
  • Cancer Immunotherapy and Biomarkers
  • Pancreatic and Hepatic Oncology Research

Throughout their career, Neuhaus has published numerous papers in leading journals. Some of the recent publications include:

  • Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma (2020), New England Journal of Medicine
  • BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update (2021), Journal of Hepatology
  • Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma (2021), Journal of Hepatology
  • Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma (2022), NEJM Evidence
  • Systemic treatment of hepatocellular carcinoma: An EASL position paper (2021), Journal of Hepatology

The publication venues where Neuhaus has contributed frequently include:

  • Journal of Hepatology
  • Journal of Clinical Oncology
  • Zeitschrift für Gastroenterologie
  • Annals of Oncology
  • Hepatology Communications

Collaborations have been a significant part of Neuhaus's research endeavors. Frequent co-authors are:

  • Christian Labenz
  • Masatoshi Kudo
  • Jörn M. Schattenberg
  • Richard S. Finn
  • Arndt Weinmann

Best Publications

  • Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

    Helmut Oettle;Stefan Post;Peter Neuhaus;Klaus Gellert

  • Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

    Vincenzo Mazzaferro;Josep M Llovet;Rosalba Miceli;Sherrie Bhoori

  • Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial

    Helmut Oettle;Peter Neuhaus;Andreas Hochhaus;Jörg Thomas Hartmann

  • Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

    Sven Jonas;Wolf O. Bechstein;Thomas Steinmüller;Martin Herrmann

  • Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)

    René Adam;Vincent Karam;Valérie Delvart;John O'Grady

  • The genetic determinants of the CYP3A5 polymorphism

    Elisabeth Hustert;Michael Haberl;Oliver Burk;Renzo Wolbold

  • Extended resections for hilar cholangiocarcinoma.

    Peter Neuhaus;Sven Jonas;Wolf O. Bechstein;Rüdiger Lohmann

  • Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.

    Thomas Lang;Kathrin Klein;Joachim Fischer;Andreas K. Nüssler

  • Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients.

    Nada Rayes;Daniel Seehofer;Sonja Hansen;Kathrin Boucsein

  • Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

    Nada Rayes;Daniel Seehofer;Tom Theruvath;Reinhold A Schiller

  • Sex is a major determinant of CYP3A4 expression in human liver

    Renzo Wolbold;Kathrin Klein;Oliver Burk;Andreas K. Nüssler

  • Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre– and post–liver transplantation patients

    Eugene R. Schiff;Ching-Lung Lai;Stefanos Hadziyannis;Peter Neuhaus

  • Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.

    Ulf P. Neumann;Thomas Berg;Marcus Bahra;Daniel Seehofer

  • Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

    Edward K. Geissler;Andreas A. Schnitzbauer;Andreas A. Schnitzbauer;Carl Zülke;Philipp E. Lamby

  • Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.

    Ina Koch;Regina Weil;Renzo Wolbold;Jürgen Brockmöller

  • Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.

    Ulf P. Neumann;Thomas Berg;Marcus Bahra;Gero Puhl

  • New staging system and a registry for perihilar cholangiocarcinoma

    Michelle L. Deoliveira;Richard D. Schulick;Yuji Nimura;Charles Rosen

  • Liver transplantation after organ preservation with normothermic extracorporeal perfusion.

    Michael R. Schön;Otto Kollmar;Stephen Wolf;Harald Schrem

  • Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity.

    Martin Stockmann;Johan F. Lock;Björn Riecke;Karsten Heyne

  • Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery

    Nada Rayes;Sonja Hansen;Daniel Seehofer;Andrea Raffaela Müller

Frequent Co-Authors

Wolf O. Bechstein
Wolf O. Bechstein Goethe University Frankfurt
Stefan G. Tullius
Stefan G. Tullius Brigham and Women's Hospital
Bertram Wiedenmann
Bertram Wiedenmann Charité - University Medicine Berlin
Wilko Weichert
Wilko Weichert Technical University of Munich
Hans-Dieter Volk
Hans-Dieter Volk Charité - University Medicine Berlin
Andreas K. Nussler
Andreas K. Nussler University of Tübingen
René Adam
René Adam University of Paris-Saclay
Petra Reinke
Petra Reinke Berlin-Brandenburger Centrum für Regenerative Therapien
Rudolf Pichlmayr
Rudolf Pichlmayr Hanover University of Applied Sciences and Arts
Rolf Rossaint
Rolf Rossaint RWTH Aachen University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degree options in healthcare can open diverse career pathways. For registered nurses seeking career advancement and increased autonomy, adn to np programs online provide accessible bridge programs to become nurse practitioners.

Healthcare administration is in demand. If you want to step into leadership roles without leaving your job, consider earning your master’s with top cahme accredited mha programs. These programs focus on management, finance, and policy, equipping graduates for high-impact positions.

Nutrition science is another fast-growing field. Those interested in food, wellness, or public health maybe want to explore online nutrition degree programs—flexible options that don’t interrupt busy lives.

Nursing professionals with an associate degree can quickly earn their bachelor’s via rn to bsn online without clinicals. These programs are designed for working RNs, offering coursework that can be completed anywhere and on your schedule.

Best Scientists Citing Peter Neuhaus

Trending Scientists

Recently Published Articles